Royce & Associates’s Corcept Therapeutics CORT Stock Holding History

Royce & Associates’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.46M	Sell	135,430 -31,132	-19%	-$1.16M	0.05%	452
2025 Q4	$5.8M	Sell	166,562 -1,997	-1%	-$157K	0.06%	439
2025 Q3	$14M	Hold	168,559	–	–	0.14%	226
2025 Q2	$12.4M	Sell	168,559 -20,755	-11%	-$1.5M	0.13%	240
2025 Q1	$21.6M	Sell	189,314 -148,986	-44%	-$9.07M	0.23%	122
2024 Q4	$17M	Sell	338,300 -24,972	-7%	-$1.31M	0.16%	184
2024 Q3	$16.8M	Buy	363,272 +13,000	+4%	+$462K	0.15%	186
2024 Q2	$11.4M	Buy	350,272 +14,000	+4%	+$384K	0.11%	272
2024 Q1	$8.47M	Buy	336,272 +197	+0.1%	+$4.65K	0.08%	375
2023 Q4	$10.9M	Sell	336,075 -17,029	-5%	-$468K	0.1%	287
2023 Q3	$9.62M	Buy	353,104 +59,363	+20%	+$1.72M	0.1%	301
2023 Q2	$6.54M	Sell	293,741 -12,513	-4%	-$288K	0.06%	435
2023 Q1	$6.63M	Buy	306,254 +46,780	+18%	+$1.03M	0.07%	420
2022 Q4	$5.27M	Sell	259,474 -13,239	-5%	-$332K	0.06%	459
2022 Q3	$6.99M	Sell	272,713 -7,737	-3%	-$207K	0.08%	359
2022 Q2	$6.67M	Buy	280,450 +69	+0%	+$1.5K	0.07%	400
2022 Q1	$6.31M	Buy	280,381 +227,477	+430%	+$4.84M	0.05%	493
2021 Q4	$1.05M	Buy	52,904 +3,041	+6%	+$61.7K	0.01%	800
2021 Q3	$981K	Sell	49,863 -2,310	-4%	-$48.3K	0.01%	820
2021 Q2	$1.15M	Sell	52,173 -270	-0.5%	-$6.01K	0.01%	834
2021 Q1	$1.25M	Sell	52,443 -8,760	-14%	-$234K	0.01%	825
2020 Q4	$1.6M	Sell	61,203 -1,503	-2%	-$31.7K	0.01%	761
2020 Q3	$1.09M	Sell	62,706 -570	-0.9%	-$9.08K	0.01%	771
2020 Q2	$1.06M	Sell	63,276 -2,165	-3%	-$30.4K	0.01%	766
2020 Q1	$778K	Sell	65,441 -1,271	-2%	-$15.7K	0.01%	772
2019 Q4	$807K	Buy	66,712 +6,915	+12%	+$96.3K	0.01%	832
2019 Q3	$845K	Buy	59,797 +20,298	+51%	+$249K	0.01%	832
2019 Q2	$440K	Buy	39,499 +17,093	+76%	+$190K	﹤0.01%	924
2019 Q1	$263K	Buy	22,406 +21,159	+1,697%	+$263K	﹤0.01%	983
2018 Q4	$17K	Sell	1,247 -371	-23%	-$4.9K	﹤0.01%	1120
2018 Q3	$23K	Buy	1,618 +871	+117%	+$12.2K	﹤0.01%	1141
2018 Q2	$12K	Buy	+747	New	+$13K	﹤0.01%	1185